US EditionCalifornia to begin selling affordable state-branded insulin beginning next year
California will sell insulin pens for $11 each starting in 2026, potentially saving patients $2,000 to $4,000 annually by bypassing major drug companies, officials said.
- California will sell low-cost insulin pens for $55 per five-pack starting January 1, 2026, as announced by Governor Gavin Newsom.
- The insulin pens will be produced by Civica Rx and will be interchangeable with Lantus, a brand of long-acting insulin.
- Governor Gavin Newsom stated that this action reflects California's commitment to healthcare affordability, ensuring that no resident must ration insulin.
- State officials aim to reduce prescription drug costs through the CalRx initiative, addressing long-standing high prices for insulin.
130 Articles
130 Articles
Times of San Diego
StocktoniaCalifornia offering $11 state-branded insulin
This story was originally published by CalMatters. Sign up for their newsletters. Starting next year, Californians with diabetes will be able to purchase state-branded insulin at steeply reduced prices, Gov. Gavin Newsom announced this week. Long-acting insulin pens will be available at pharmacies for $11 per pen — or $55 for a five-pack — beginning Jan. 1. The pens are interchangeable with glargine, the generic alternative for Lantus, a once-a…
Newsom Says California Will Start Selling Its Own $11 Insulin Pens Next Year
California Gov. Gavin Newsom announced on Oct. 16 that the state would start selling its own brand of affordable insulin pens next year to improve access to essential medication across the state. The insulin pens will be sold under the state’s CalRx brand for $11 per pen or $55 per five-pack, with sales expected to begin on Jan. 1, 2026, according to a statement from the governor’s office. This follows an agreement reached by California with dru…
California takes on pharma giants with plans to sell its own insulin
After a three-year effort, California will start selling low-cost insulin pens this January, the first such move by a state to circumvent the pharmaceutical industry and combat diabetes. A pack of five pens will be made available for $55 through the CalRx program, which was initiated five years ago by California Gov. Gavin Newsom to bring less expensive medicines to state residents. The program contracts with companies to make generic drugs and,…
Governor Gavin Newsom said that since January 1, 2026, California residents will have access to insulin, at a cost of $11 per unit
Los Angeles, Oct 16 (EFE).- California will start selling low-cost insulin from its own brand as of January 1, 2026, making the state the first in the country to sell generic drugs produced with state investment. California’s governor, Democrat Gavin Newsom, announced this Thursday that from next year each CalRx insulin pen will start selling at $11. The announcement comes almost three years after California signed an agreement with Civica Rx, a…
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
